U.S., Aug. 15 -- ClinicalTrials.gov registry received information related to the study (NCT07766122) titled 'Analysis of the Performance of PSMA Emission Tomography in Patients With Prostate Cancer Treated With HIFU' on Aug. 10.

Brief Summary: There would appear to be a strong interest in functional nuclear imaging for assessing the response to focal PaC treatment. Investigator team hypothesise that the diagnostic performance of PSMA PET is noninferior to that of MRI in detecting clinically significant recurrent PaC after treatment with HIFU. The main objective was to evaluate the diagnostic performance of PSMA PET compared with MRI with reference to the gold standard of prostate biopsy one year after HIFU.

Study Start Date: Oct., 2026

S...